SPOTLIGHT: Device makers team up on stent safety study

Earlier this year, medical device giants Johnson & Johnson and Boston Scientific were involved in a knock-down, drag out fight over the acquisition of Guidant. But in light of recent reports that blood clots can form within drug-coated stents, the former rivals as well as several other device makers have come together to fund a 10,000-person study of the technology. Report

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.